98%
921
2 minutes
20
The diversity of noncovalent interactions makes the design space of multicomponent molecular systems highly complex. To efficiently explore supramolecular design space, data-driven strategies are needed. Here, we demonstrate a methodological framework for the targeted design of multicomponent molecular systems with noncovalent interactions using Bayesian optimization. Its effective applicability to supramolecular polymers is illustrated by three representative cases that reveal accelerated exploration of diverse multicomponent systems with a universal Bayesian optimization framework. The number of experiments required to arrive at optimal compositions is significantly reduced compared to random or uninformed sampling strategies, enabling the experimental study of high-dimensional design spaces. In this way, we can tune the formulation of intricate mixtures and achieve tailored macroscopic properties with minimal experimental effort. Our results show that Bayesian optimization is a general tool for developing multicomponent supramolecular systems with designed functionality.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/jacs.5c08539 | DOI Listing |
Rev Sci Instrum
September 2025
Joint Quantum Institute, University of Maryland and National Institute of Standards and Technology, College Park, Maryland 20742, USA.
We describe an apparatus that efficiently produces 23Na Bose-Einstein condensates (BECs) in a hybrid trap that combines a quadrupole magnetic field with a far-detuned optical dipole trap. Using a Bayesian optimization framework, we systematically optimize all BEC production parameters in modest-sized batches of highly correlated parameters. Furthermore, we introduce a Lagrange multiplier-based technique to optimize the duration of different evaporation stages constrained to have a fixed total duration; this enables the progressive creation of increasingly rapid experimental sequences that still generate high-quality BECs.
View Article and Find Full Text PDFPhys Ther
September 2025
Dirección de Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Importance: To this author's knowledge, this is the first study to examine the burden of rehabilitation-relevant conditions in Mexico, providing valuable evidence to inform public policy and enhance the delivery of rehabilitation services.
Objective: This study presents a national-level analysis estimating the number of people in Mexico who required rehabilitation at least once during the course of an illness or injury that caused a disability, based on data from the 2021 Global Burden of Disease Study.
Design: This was a cross-sectional analysis.
Clin Gastroenterol Hepatol
September 2025
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. Electronic address:
Background And Aims: Infliximab and ustekinumab clearance have been suggested as predictors of disease activity in patients with inflammatory bowel diseases. We aimed to investigate the benefits of clearance monitoring for predicting endoscopic outcomes in patients with Crohn's disease (CD).
Methods: Data from patients with moderate-to-severe CD starting infliximab (n=108) and ustekinumab (n=80) therapy were repurposed.
Comput Biol Chem
September 2025
Department of Biotechnology, Deenbandhu Chhotu Ram University of Science & Technology, Murthal, Haryana 131039, India. Electronic address:
Lentinula edodes (shiitake mushroom) is a widely cultivated edible and medicinal fungus, valued for its bioactive compounds. While East Asian strains have been well studied, Indian populations remain under-characterized. This study explores the genetic and functional diversity of five Indian-origin L.
View Article and Find Full Text PDFAnn Surg Oncol
September 2025
Surgical Oncology, The Institute for Cancer Care, Mercy Medical Center, Baltimore, MD, USA.
Introduction: The optimal surveillance for mucinous appendix cancer (MAC) after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) remains unclear. We identified postoperative periods reflecting significant changes in recurrence probability.
Methods: A prospective database (1998-2024) of patients with stage IV MAC with low-grade (LGMCP), high-grade (HGMCP), and signet-ring cell (SRC) histology treated with initial complete (CC-0/1) CRS/HIPEC was analyzed.